{"id":189268,"date":"2026-02-10T09:36:56","date_gmt":"2026-02-10T08:36:56","guid":{"rendered":"https:\/\/www.gpigroup.com\/?p=189268"},"modified":"2026-02-24T09:40:03","modified_gmt":"2026-02-24T08:40:03","slug":"sentinel-eyes-securite-transfusionnelle","status":"publish","type":"post","link":"https:\/\/www.gpigroup.com\/fr\/news\/sentinel-eyes-securite-transfusionnelle\/","title":{"rendered":"Sentinel-Eyes : Une technologie au service de la s\u00e9curit\u00e9 transfusionnelle"},"content":{"rendered":"<p>Dans les coulisses du lancement de Sentinel-Eyes, une question revient souvent : comment fonctionne concr\u00e8tement cette solution innovante d\u00e9di\u00e9e \u00e0 la gestion des produits sanguins labiles (PSL) ? Pens\u00e9e pour r\u00e9pondre aux besoins des \u00e9tablissements de sant\u00e9, notamment ceux \u00e9loign\u00e9s ou sous-dot\u00e9s, Sentinel-Eyes propose une approche int\u00e9gr\u00e9e, s\u00e9curis\u00e9e et contr\u00f4lable \u00e0 distance.<\/p>\n<p>Son objectif ? Faciliter la mise \u00e0 disposition des poches de sang tout en garantissant leur tra\u00e7abilit\u00e9 et leur conformit\u00e9, depuis leur r\u00e9ception jusqu\u2019\u00e0 leur d\u00e9livrance au patient.<\/p>\n<p><b>Une architecture connect\u00e9e et s\u00e9curis\u00e9e<\/b><\/p>\n<p>Sentinel-Eyes repose sur une infrastructure hybride, combinant cloud s\u00e9curis\u00e9 (HDS \u2013 SecNumCloud) et r\u00e9seau local d\u00e9di\u00e9. Les connexions entre les centres de soins et l\u2019environnement Sentinel-Eyes sont prot\u00e9g\u00e9es par des tunnels VPN IPSec, assurant la confidentialit\u00e9 des donn\u00e9es de sant\u00e9 et la conformit\u00e9 RGPD.<\/p>\n<p><b>Des \u00e9quipements intelligents au c\u0153ur du dispositif<\/b><\/p>\n<p>Au centre du syst\u00e8me, on retrouve le r\u00e9frig\u00e9rateur m\u00e9dical B Medical B-501, \u00e9quip\u00e9 de lecteurs RFID PJM et de bacs adapt\u00e9s au stockage des poches. Chaque PSL est identifi\u00e9 par une puce StackTag sans batterie, capable de r\u00e9sister \u00e0 des temp\u00e9ratures extr\u00eames et de transmettre ses donn\u00e9es en temps r\u00e9el.<\/p>\n<p><i><img loading=\"lazy\" decoding=\"async\" class=\"alignnone size-medium wp-image-189282\" src=\"https:\/\/www.gpigroup.com\/app\/uploads\/2026\/02\/Kais-Dammak-278x300.jpg\" alt=\"\" width=\"278\" height=\"300\" srcset=\"https:\/\/www.gpigroup.com\/app\/uploads\/2026\/02\/Kais-Dammak-278x300.jpg 278w, https:\/\/www.gpigroup.com\/app\/uploads\/2026\/02\/Kais-Dammak.jpg 651w\" sizes=\"auto, (max-width: 278px) 100vw, 278px\" \/><\/i><\/p>\n<p><i>\u00ab Lorsqu\u2019une poche doit \u00eatre pr\u00e9lev\u00e9e, un signal est envoy\u00e9 : il permet d\u2019activer une diode \u00e9lectroluminescente via une induction \u00e9lectromagn\u00e9tique sur la poche, \u00e9liminant ainsi toute possibilit\u00e9 d\u2019erreur humaine. \u00bb<\/i><\/p>\n<p>\u2014 Kais Dammak, GPI France<\/p>\n<p><b>Un pilotage logiciel centralis\u00e9 avec Cursus<\/b><\/p>\n<p>Le logiciel Sentinel-Eyes, d\u00e9velopp\u00e9 par GPI France, pilote l\u2019ensemble du dispositif. Il g\u00e8re les droits d\u2019acc\u00e8s, identifie les op\u00e9rateurs, contr\u00f4le les mouvements des PSL et assure la tra\u00e7abilit\u00e9 compl\u00e8te des op\u00e9rations. Chaque action \u2013 retrait, mise en stock, quarantaine \u2013 est historis\u00e9e et associ\u00e9e \u00e0 un identifiant unique.<\/p>\n<p><i>\u00ab Le premier avantage, c\u2019est une s\u00e9curit\u00e9 accrue et inclusive : quel que soit l\u2019endroit o\u00f9 l\u2019on se trouve, le niveau de s\u00e9curit\u00e9 et de performance de la distribution reste identique. \u00bb<\/i><\/p>\n<p>\u2014 Michel Angu\u00e9, directeur commercial, GPI France<\/p>\n<p><iframe loading=\"lazy\" title=\"YouTube video player\" src=\"https:\/\/www.youtube.com\/embed\/73S6RpTINMA?si=eSpkmsV73qJOPgrd\" width=\"560\" height=\"315\" frameborder=\"0\" allowfullscreen=\"allowfullscreen\"><\/iframe><\/p>\n<p><b>Une d\u00e9livrance guid\u00e9e et s\u00e9curis\u00e9e<\/b><\/p>\n<p>Le processus de d\u00e9livrance est enti\u00e8rement guid\u00e9 :<\/p>\n<ul>\n<li>L\u2019op\u00e9rateur s\u2019identifie et scanne l\u2019identifiant du patient.<\/li>\n<li>L\u2019enceinte s\u2019ouvre uniquement si les conditions sont r\u00e9unies.<\/li>\n<li>Le syst\u00e8me guide l\u2019utilisateur vers le bon compartiment.<\/li>\n<li>Un contr\u00f4le crois\u00e9 valide la s\u00e9lection avant impression du document de d\u00e9livrance.<\/li>\n<\/ul>\n<p>En cas d\u2019erreur, une alarme sonore et visuelle est d\u00e9clench\u00e9e, bloquant l\u2019op\u00e9ration. Le document de d\u00e9livrance ne peut \u00eatre \u00e9dit\u00e9 qu\u2019\u00e0 l\u2019issue compl\u00e8te du processus, garantissant la conformit\u00e9 r\u00e9glementaire.<\/p>\n<p><b>Une gestion proactive des urgences et des quarantaines<\/b><\/p>\n<p>Sentinel-Eyes int\u00e8gre un mode d\u00e9grad\u00e9 pour les situations d\u2019urgence : d\u00e9livrance de CGR de groupe O non r\u00e9serv\u00e9s, saisie manuelle de l\u2019identit\u00e9 patient, reprise des mouvements apr\u00e8s r\u00e9tablissement de la connexion. Les PSL remis en stock sont automatiquement plac\u00e9s en quarantaine, avec historisation des temp\u00e9ratures et des donn\u00e9es de conservation.<\/p>\n<p><b>Une tra\u00e7abilit\u00e9 compl\u00e8te, locale et distante<\/b><\/p>\n<p>Chaque mouvement est transmis au LMT de l\u2019EFS en temps r\u00e9el. L\u2019interface permet une consultation distante des stocks, du plan d\u2019occupation des enceintes, des alarmes et des historiques. Les donn\u00e9es sont export\u00e9es automatiquement, assurant une tra\u00e7abilit\u00e9 int\u00e9grale des \u00e9tapes, horaires, patients et op\u00e9rateurs impliqu\u00e9s.<\/p>\n<p><b>Une solution \u00e9coresponsable et \u00e9volutive<\/b><\/p>\n<p>Sentinel-Eyes permet le r\u00e9trofit des \u00e9quipements B Medical existants, r\u00e9duisant les co\u00fbts et l\u2019impact environnemental. La gestion des stocks porte ferm\u00e9e diminue les consommations \u00e9nerg\u00e9tiques, et les puces RFID sans batterie limitent l\u2019usage de composants polluants.<\/p>\n<p><i><img loading=\"lazy\" decoding=\"async\" class=\"alignnone size-medium wp-image-189294\" src=\"https:\/\/www.gpigroup.com\/app\/uploads\/2026\/02\/Kevin-Laville-photo-271x300.png\" alt=\"\" width=\"271\" height=\"300\" srcset=\"https:\/\/www.gpigroup.com\/app\/uploads\/2026\/02\/Kevin-Laville-photo-271x300.png 271w, https:\/\/www.gpigroup.com\/app\/uploads\/2026\/02\/Kevin-Laville-photo.png 341w\" sizes=\"auto, (max-width: 271px) 100vw, 271px\" \/><\/i><\/p>\n<p><i>\u00ab Nous pouvons op\u00e9rer un r\u00e9trofit de tous vos \u00e9quipements B Medical de moins de 5 ans. Cela permet une \u00e9conomie budg\u00e9taire tout en rationnalisant l&#8217;utilisation de mati\u00e8res premi\u00e8res. \u00bb<\/i><\/p>\n<p>\u2014 K\u00e9vin Laville, B Medical Systems<\/p>\n<p><b>Une prise en charge plus rapide, m\u00eame \u00e0 distance<\/b><\/p>\n<p>Gr\u00e2ce \u00e0 l\u2019identification instantan\u00e9e des poches n\u00e9cessaires, le geste des personnels est s\u00e9curis\u00e9 et acc\u00e9l\u00e9r\u00e9. Que l\u2019on soit dans un CHU ou un h\u00f4pital de proximit\u00e9, Sentinel-Eyes garantit un niveau d\u2019expertise et d\u2019efficacit\u00e9 homog\u00e8ne.<\/p>\n<blockquote class=\"\" data-path-to-node=\"1\">\n<p data-path-to-node=\"1,0\"><b data-path-to-node=\"1,0\" data-index-in-node=\"0\">En savoir plus<\/b><\/p>\n<\/blockquote>\n<ul>\n<li>\n<div role=\"presentation\"><a href=\"https:\/\/www.gpigroup.com\/fr\/news\/sentinel-eyes-une-nouvelle-ere-pour-la-gestion-des-produits-sanguins-labiles\/\" target=\"_blank\" rel=\"noopener\" data-saferedirecturl=\"https:\/\/www.google.com\/url?q=https:\/\/www.gpigroup.com\/fr\/news\/sentinel-eyes-une-nouvelle-ere-pour-la-gestion-des-produits-sanguins-labiles\/&amp;source=gmail&amp;ust=1772007846226000&amp;usg=AOvVaw1o041bS2GyRYgb5O3HSNgg\">Sentinel-Eyes<\/a><\/div>\n<\/li>\n<li>\n<div role=\"presentation\"><a href=\"https:\/\/www.gpigroup.com\/fr\/gpi4med-blood-24\/\" target=\"_blank\" rel=\"noopener\" data-saferedirecturl=\"https:\/\/www.google.com\/url?q=https:\/\/www.gpigroup.com\/fr\/gpi4med-blood-24\/&amp;source=gmail&amp;ust=1772007846226000&amp;usg=AOvVaw03LqnyjC8I_QAnfmYG-TmT\">GPI4Med Blood<wbr \/>gpi4med-blood-24<\/a><\/div>\n<\/li>\n<li>\n<div role=\"presentation\">Contact us:<a href=\"mailto:commercial@gpifrance.fr\" target=\"_blank\" rel=\"noopener\">: commercial@gpifrance.fr<\/a><\/div>\n<\/li>\n<\/ul>\n","protected":false},"excerpt":{"rendered":"<p>Sentinel-Eyes s\u00e9curise la gestion des produits sanguins gr\u00e2ce \u00e0 une solution connect\u00e9e et intelligente. Cette technologie assure une tra\u00e7abilit\u00e9 en temps r\u00e9el et une d\u00e9livrance guid\u00e9e, garantissant une s\u00e9curit\u00e9 transfusionnelle optimale, m\u00eame pour les \u00e9tablissements de sant\u00e9 isol\u00e9s.<\/p>\n","protected":false},"author":7,"featured_media":165865,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1414],"tags":[],"class_list":["post-189268","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-nouvelle"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.1.1 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Sentinel-Eyes : S\u00e9curit\u00e9 et tra\u00e7abilit\u00e9 transfusionnelle<\/title>\n<meta name=\"description\" content=\"D\u00e9couvrez comment Sentinel-Eyes s\u00e9curise la gestion des PSL gr\u00e2ce \u00e0 une technologie connect\u00e9e. Tra\u00e7abilit\u00e9 en temps r\u00e9el et d\u00e9livrance guid\u00e9e pour les h\u00f4pitaux.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.gpigroup.com\/fr\/news\/sentinel-eyes-securite-transfusionnelle\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Sentinel-Eyes : S\u00e9curit\u00e9 et tra\u00e7abilit\u00e9 transfusionnelle\" \/>\n<meta property=\"og:description\" content=\"D\u00e9couvrez comment Sentinel-Eyes s\u00e9curise la gestion des PSL gr\u00e2ce \u00e0 une technologie connect\u00e9e. Tra\u00e7abilit\u00e9 en temps r\u00e9el et d\u00e9livrance guid\u00e9e pour les h\u00f4pitaux.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.gpigroup.com\/fr\/news\/sentinel-eyes-securite-transfusionnelle\/\" \/>\n<meta property=\"og:site_name\" content=\"GPI\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/GruppoGPI\/\" \/>\n<meta property=\"article:published_time\" content=\"2026-02-10T08:36:56+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-02-24T08:40:03+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.gpigroup.com\/app\/uploads\/2025\/02\/Certificazione-MDMA.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1920\" \/>\n\t<meta property=\"og:image:height\" content=\"1282\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Manlio Milazzi\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Manlio Milazzi\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"4 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/www.gpigroup.com\/fr\/news\/sentinel-eyes-securite-transfusionnelle\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/www.gpigroup.com\/fr\/news\/sentinel-eyes-securite-transfusionnelle\/\"},\"author\":{\"name\":\"Manlio Milazzi\",\"@id\":\"https:\/\/www.gpigroup.com\/fr\/#\/schema\/person\/5d13949c66ade9c548a72f6f1e50299f\"},\"headline\":\"Sentinel-Eyes : Une technologie au service de la s\u00e9curit\u00e9 transfusionnelle\",\"datePublished\":\"2026-02-10T08:36:56+00:00\",\"dateModified\":\"2026-02-24T08:40:03+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/www.gpigroup.com\/fr\/news\/sentinel-eyes-securite-transfusionnelle\/\"},\"wordCount\":753,\"publisher\":{\"@id\":\"https:\/\/www.gpigroup.com\/fr\/#organization\"},\"image\":{\"@id\":\"https:\/\/www.gpigroup.com\/fr\/news\/sentinel-eyes-securite-transfusionnelle\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.gpigroup.com\/app\/uploads\/2025\/02\/Certificazione-MDMA.jpg\",\"articleSection\":[\"Nouvelle\"],\"inLanguage\":\"fr-FR\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.gpigroup.com\/fr\/news\/sentinel-eyes-securite-transfusionnelle\/\",\"url\":\"https:\/\/www.gpigroup.com\/fr\/news\/sentinel-eyes-securite-transfusionnelle\/\",\"name\":\"Sentinel-Eyes : S\u00e9curit\u00e9 et tra\u00e7abilit\u00e9 transfusionnelle\",\"isPartOf\":{\"@id\":\"https:\/\/www.gpigroup.com\/fr\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.gpigroup.com\/fr\/news\/sentinel-eyes-securite-transfusionnelle\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.gpigroup.com\/fr\/news\/sentinel-eyes-securite-transfusionnelle\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.gpigroup.com\/app\/uploads\/2025\/02\/Certificazione-MDMA.jpg\",\"datePublished\":\"2026-02-10T08:36:56+00:00\",\"dateModified\":\"2026-02-24T08:40:03+00:00\",\"description\":\"D\u00e9couvrez comment Sentinel-Eyes s\u00e9curise la gestion des PSL gr\u00e2ce \u00e0 une technologie connect\u00e9e. Tra\u00e7abilit\u00e9 en temps r\u00e9el et d\u00e9livrance guid\u00e9e pour les h\u00f4pitaux.\",\"breadcrumb\":{\"@id\":\"https:\/\/www.gpigroup.com\/fr\/news\/sentinel-eyes-securite-transfusionnelle\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.gpigroup.com\/fr\/news\/sentinel-eyes-securite-transfusionnelle\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\/\/www.gpigroup.com\/fr\/news\/sentinel-eyes-securite-transfusionnelle\/#primaryimage\",\"url\":\"https:\/\/www.gpigroup.com\/app\/uploads\/2025\/02\/Certificazione-MDMA.jpg\",\"contentUrl\":\"https:\/\/www.gpigroup.com\/app\/uploads\/2025\/02\/Certificazione-MDMA.jpg\",\"width\":1920,\"height\":1282},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.gpigroup.com\/fr\/news\/sentinel-eyes-securite-transfusionnelle\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.gpigroup.com\/fr\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Sentinel-Eyes : Une technologie au service de la s\u00e9curit\u00e9 transfusionnelle\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.gpigroup.com\/fr\/#website\",\"url\":\"https:\/\/www.gpigroup.com\/fr\/\",\"name\":\"GPI\",\"description\":\"The Healthcare Partner\",\"publisher\":{\"@id\":\"https:\/\/www.gpigroup.com\/fr\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.gpigroup.com\/fr\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.gpigroup.com\/fr\/#organization\",\"name\":\"GPI S.p.A.\",\"url\":\"https:\/\/www.gpigroup.com\/fr\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\/\/www.gpigroup.com\/fr\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.gpigroup.com\/app\/uploads\/2023\/03\/logo-GPI-2019-1.jpg\",\"contentUrl\":\"https:\/\/www.gpigroup.com\/app\/uploads\/2023\/03\/logo-GPI-2019-1.jpg\",\"width\":1946,\"height\":1945,\"caption\":\"GPI S.p.A.\"},\"image\":{\"@id\":\"https:\/\/www.gpigroup.com\/fr\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/GruppoGPI\/\",\"https:\/\/www.linkedin.com\/company\/gpi-spa\",\"http:\/\/www.youtube.com\/user\/GruppoGPI\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.gpigroup.com\/fr\/#\/schema\/person\/5d13949c66ade9c548a72f6f1e50299f\",\"name\":\"Manlio Milazzi\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\/\/www.gpigroup.com\/fr\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/f0fe3eaa7d2ec35f67b70dbab0f1281c1ce1f37f8c8aa334c78dedb413d7d7c7?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/f0fe3eaa7d2ec35f67b70dbab0f1281c1ce1f37f8c8aa334c78dedb413d7d7c7?s=96&d=mm&r=g\",\"caption\":\"Manlio Milazzi\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Sentinel-Eyes : S\u00e9curit\u00e9 et tra\u00e7abilit\u00e9 transfusionnelle","description":"D\u00e9couvrez comment Sentinel-Eyes s\u00e9curise la gestion des PSL gr\u00e2ce \u00e0 une technologie connect\u00e9e. Tra\u00e7abilit\u00e9 en temps r\u00e9el et d\u00e9livrance guid\u00e9e pour les h\u00f4pitaux.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.gpigroup.com\/fr\/news\/sentinel-eyes-securite-transfusionnelle\/","og_locale":"fr_FR","og_type":"article","og_title":"Sentinel-Eyes : S\u00e9curit\u00e9 et tra\u00e7abilit\u00e9 transfusionnelle","og_description":"D\u00e9couvrez comment Sentinel-Eyes s\u00e9curise la gestion des PSL gr\u00e2ce \u00e0 une technologie connect\u00e9e. Tra\u00e7abilit\u00e9 en temps r\u00e9el et d\u00e9livrance guid\u00e9e pour les h\u00f4pitaux.","og_url":"https:\/\/www.gpigroup.com\/fr\/news\/sentinel-eyes-securite-transfusionnelle\/","og_site_name":"GPI","article_publisher":"https:\/\/www.facebook.com\/GruppoGPI\/","article_published_time":"2026-02-10T08:36:56+00:00","article_modified_time":"2026-02-24T08:40:03+00:00","og_image":[{"width":1920,"height":1282,"url":"https:\/\/www.gpigroup.com\/app\/uploads\/2025\/02\/Certificazione-MDMA.jpg","type":"image\/jpeg"}],"author":"Manlio Milazzi","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Manlio Milazzi","Est. reading time":"4 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.gpigroup.com\/fr\/news\/sentinel-eyes-securite-transfusionnelle\/#article","isPartOf":{"@id":"https:\/\/www.gpigroup.com\/fr\/news\/sentinel-eyes-securite-transfusionnelle\/"},"author":{"name":"Manlio Milazzi","@id":"https:\/\/www.gpigroup.com\/fr\/#\/schema\/person\/5d13949c66ade9c548a72f6f1e50299f"},"headline":"Sentinel-Eyes : Une technologie au service de la s\u00e9curit\u00e9 transfusionnelle","datePublished":"2026-02-10T08:36:56+00:00","dateModified":"2026-02-24T08:40:03+00:00","mainEntityOfPage":{"@id":"https:\/\/www.gpigroup.com\/fr\/news\/sentinel-eyes-securite-transfusionnelle\/"},"wordCount":753,"publisher":{"@id":"https:\/\/www.gpigroup.com\/fr\/#organization"},"image":{"@id":"https:\/\/www.gpigroup.com\/fr\/news\/sentinel-eyes-securite-transfusionnelle\/#primaryimage"},"thumbnailUrl":"https:\/\/www.gpigroup.com\/app\/uploads\/2025\/02\/Certificazione-MDMA.jpg","articleSection":["Nouvelle"],"inLanguage":"fr-FR"},{"@type":"WebPage","@id":"https:\/\/www.gpigroup.com\/fr\/news\/sentinel-eyes-securite-transfusionnelle\/","url":"https:\/\/www.gpigroup.com\/fr\/news\/sentinel-eyes-securite-transfusionnelle\/","name":"Sentinel-Eyes : S\u00e9curit\u00e9 et tra\u00e7abilit\u00e9 transfusionnelle","isPartOf":{"@id":"https:\/\/www.gpigroup.com\/fr\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.gpigroup.com\/fr\/news\/sentinel-eyes-securite-transfusionnelle\/#primaryimage"},"image":{"@id":"https:\/\/www.gpigroup.com\/fr\/news\/sentinel-eyes-securite-transfusionnelle\/#primaryimage"},"thumbnailUrl":"https:\/\/www.gpigroup.com\/app\/uploads\/2025\/02\/Certificazione-MDMA.jpg","datePublished":"2026-02-10T08:36:56+00:00","dateModified":"2026-02-24T08:40:03+00:00","description":"D\u00e9couvrez comment Sentinel-Eyes s\u00e9curise la gestion des PSL gr\u00e2ce \u00e0 une technologie connect\u00e9e. Tra\u00e7abilit\u00e9 en temps r\u00e9el et d\u00e9livrance guid\u00e9e pour les h\u00f4pitaux.","breadcrumb":{"@id":"https:\/\/www.gpigroup.com\/fr\/news\/sentinel-eyes-securite-transfusionnelle\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.gpigroup.com\/fr\/news\/sentinel-eyes-securite-transfusionnelle\/"]}]},{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/www.gpigroup.com\/fr\/news\/sentinel-eyes-securite-transfusionnelle\/#primaryimage","url":"https:\/\/www.gpigroup.com\/app\/uploads\/2025\/02\/Certificazione-MDMA.jpg","contentUrl":"https:\/\/www.gpigroup.com\/app\/uploads\/2025\/02\/Certificazione-MDMA.jpg","width":1920,"height":1282},{"@type":"BreadcrumbList","@id":"https:\/\/www.gpigroup.com\/fr\/news\/sentinel-eyes-securite-transfusionnelle\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.gpigroup.com\/fr\/"},{"@type":"ListItem","position":2,"name":"Sentinel-Eyes : Une technologie au service de la s\u00e9curit\u00e9 transfusionnelle"}]},{"@type":"WebSite","@id":"https:\/\/www.gpigroup.com\/fr\/#website","url":"https:\/\/www.gpigroup.com\/fr\/","name":"GPI","description":"The Healthcare Partner","publisher":{"@id":"https:\/\/www.gpigroup.com\/fr\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.gpigroup.com\/fr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"},{"@type":"Organization","@id":"https:\/\/www.gpigroup.com\/fr\/#organization","name":"GPI S.p.A.","url":"https:\/\/www.gpigroup.com\/fr\/","logo":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/www.gpigroup.com\/fr\/#\/schema\/logo\/image\/","url":"https:\/\/www.gpigroup.com\/app\/uploads\/2023\/03\/logo-GPI-2019-1.jpg","contentUrl":"https:\/\/www.gpigroup.com\/app\/uploads\/2023\/03\/logo-GPI-2019-1.jpg","width":1946,"height":1945,"caption":"GPI S.p.A."},"image":{"@id":"https:\/\/www.gpigroup.com\/fr\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/GruppoGPI\/","https:\/\/www.linkedin.com\/company\/gpi-spa","http:\/\/www.youtube.com\/user\/GruppoGPI"]},{"@type":"Person","@id":"https:\/\/www.gpigroup.com\/fr\/#\/schema\/person\/5d13949c66ade9c548a72f6f1e50299f","name":"Manlio Milazzi","image":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/www.gpigroup.com\/fr\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/f0fe3eaa7d2ec35f67b70dbab0f1281c1ce1f37f8c8aa334c78dedb413d7d7c7?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/f0fe3eaa7d2ec35f67b70dbab0f1281c1ce1f37f8c8aa334c78dedb413d7d7c7?s=96&d=mm&r=g","caption":"Manlio Milazzi"}}]}},"_links":{"self":[{"href":"https:\/\/www.gpigroup.com\/fr\/wp-json\/wp\/v2\/posts\/189268","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.gpigroup.com\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.gpigroup.com\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.gpigroup.com\/fr\/wp-json\/wp\/v2\/users\/7"}],"replies":[{"embeddable":true,"href":"https:\/\/www.gpigroup.com\/fr\/wp-json\/wp\/v2\/comments?post=189268"}],"version-history":[{"count":3,"href":"https:\/\/www.gpigroup.com\/fr\/wp-json\/wp\/v2\/posts\/189268\/revisions"}],"predecessor-version":[{"id":189331,"href":"https:\/\/www.gpigroup.com\/fr\/wp-json\/wp\/v2\/posts\/189268\/revisions\/189331"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.gpigroup.com\/fr\/wp-json\/wp\/v2\/media\/165865"}],"wp:attachment":[{"href":"https:\/\/www.gpigroup.com\/fr\/wp-json\/wp\/v2\/media?parent=189268"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.gpigroup.com\/fr\/wp-json\/wp\/v2\/categories?post=189268"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.gpigroup.com\/fr\/wp-json\/wp\/v2\/tags?post=189268"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}